Author: García-Sanz Ramón
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.7, Iss.2, 2006-02, pp. : 195-213
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Thalidomide in Multiple Myeloma
Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. :
Thalidomide improves response rate, survival in multiple myeloma
Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. :
Thalidomide benefits patients with refractory multiple myeloma
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :